Spironolactone in the management of congestive heart failure.
Kayser
S R
SR
Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, USA.
D004232:Diuretics / Q000494:pharmacology / Q000627:therapeutic use*; D006333:Heart Failure / Q000145:classification / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D004232:Diuretics; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone